Differential effects of intrathecally and intracerebroventricularly administered nitric oxide donors on noxious mechanical and thermal stimulation

Polish Journal of Pharmacology

Volumn 50, Issue 6, 1998, Pages 407-415

  Machelska, Halina ^a   Przewłocki, Ryszard ^a   Radomski, Marek W ^b   Przewłocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Brain; Hyperalgesia; Mechanical stimulation; Nitric oxide; Nitric oxide donors; Spinal cord; Thermal stimulation

Indexed keywords

CYCLIC GMP; HEMOGLOBIN; HYDROXYLAMINE; LINSIDOMINE; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOGLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; RAT; SPINAL CORD; THERMAL STIMULATION;

ANIMALS; DRUG INTERACTIONS; HEAT; HYPERALGESIA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NOCICEPTORS; PAIN MEASUREMENT; PHYSICAL STIMULATION; RATS; RATS, WISTAR; SPINAL CORD;

EID: 0032450043     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bredt D. S., Glatt C. E., Hwang P. M., Fotuchi M., Dawson T. M., Snyder S. H.: Nitric oxide synthase protein and mRNA are discretly localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron, 1991, 7, 615-624.
2. Bredt D. S., Snyder S. H.: Nitric oxide, a novel neuronal messenger. Neuron, 1992, 8, 3-11.
3. Carr P. A., Nagy J. I.: Emerging relationships between cytochemical properties and sensory modality transmission in primary sensory neurons. Brain Res. Bull.,1993, 30, 209-219.
4. Cohn M. L., Cohn M., Taylor F. H.: Guanosine 3′,5′-monophosphate: a central nervous system regulator of analgesia. Science, 1978, 199, 319-322.
5. Duarte I. D. G., Ferreira S. H.: The molecular mechanism of central induced antinociception by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol.,1992, 221, 171-174.
6. Dun N. J., Dun S. L., Wu S. Y., Forstermann U., Schmidt H. H. H. W., Tseng L F.: Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience, 1993, 54, 845-857.
7. Fiallos-Estrada C. E., Kummer W., Mayer B., Bravo R., Zimmermann M., Herdegen T.: Long-lasting increase of nitric oxide synthase immunoreactivity, NADPH-diaphorase reaction and c-Jun co-expression in rat dorsal root ganglion neurons following sciatic nerve transsection. Neurosci. Lett.,1993, 150, 169-173.
8. Carry M. G., Abraham E., Hargreaves K. M., Aanonsen L. M.: Intrathecal injection of cell-permeable analogs of cyclic 3′,5′-guanosine monophosphate produces hyperalgesia in mice. Eur. J. Pharmacol.,1994, 260, 129-131.
9. Garry M. G., Richardson J. D., Hargreaves K. M.: Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res.,1994, 646, 135-139.
10. Garry M. G., Richardson J. D., Hargreaves K. M.: Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J. Neurosci.,1994, 14, 4329-4337.
11. Garthwaite J.: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci.,1991, 14, 60-67.
12. Guevara-Guzman R.,Emson P. C., Kendrick K.: Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem.,1994, 62, 807-810.
13. Haley J. E., Dickenson A. H. Schachter M.: Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology, 1992, 31, 251-258.
14. Hao J. X., Xu X. J.: Treatment of a chronic allodynia-like response in spinally injured rats. Effects of systemically administered nitric oxide synthase inhibitors. Pain, 1996, 66, 313-319.
15. Herdegen T.,Rudiger S., Mayer B., Bravo R., Zimmermann M.: Expression of nitric oxide synthase and colocalization with Jun, Fos and Krox transcription factors in spinal cord neurons following noxious stimulation of the rat hind paw. Mol. Brain Res.,1994, 22, 245-258.
16. Holthusen H.,Arndt J. O.: Nitric oxide evokes pain in humans on intracutaneous injection. Neurosci. Lett.,1994, 165, 71-74.
17. Kawabata A.,Manabe S., Manabe Y., Takagi H.: Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Brit. J. Pharmacol.,1994, 112, 547-550.
18. Kawabata A.,Umeda N., Takagi H.: L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Brit. J. Pharmacol.,1993, 109, 73-79.
19. Kitto K. F., Haley J. E., Wilcox G. L.: Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett.,1992, 148, 1-5.
20. Lee J.-H., Wilcox G. L., Beitz A. J.: Nitric oxide mediates Fos expression in the spinal cord induced by mechanical noxious stimulation. NeuroReport, 1992, 3, 841-844.
21. Lei S. Z., Pan Z.-H., Aggarwal S. K., Chen H.-S. V., Hartman J., Sucher N. J., Lipton S. A.: Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron, 1992, 8, 1087-1099.
22. Levy R. A., Proudfit H. K., Goldstein B. D.: Antinociception following microinjection of dibutyryl cyclic nucleotides into the caudal reticular formation and periaqueductal gray of the rat brain. Pharmacol. Biochem. Behav.,1983, 19, 79-84.
23. Lipton S. A., Choi Y.-B., Sucher N. J., Pan Z.-H., Stamler J. S.: Redox state, NMDA receptors and NO-related species. Trends Pharmacol. Sci.,1996, 17, 186-187.
24. Luo D.,Das S., Vincent R. S.: Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur. J. Pharmacol.-Molec. Pharm., 1995, 290, 247-251.